Cargando…
First-line treatment and survival of newly diagnosed primary plasma cell leukemia patients in the Netherlands: a population-based study, 1989-2018
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873037/ https://www.ncbi.nlm.nih.gov/pubmed/33563890 http://dx.doi.org/10.1038/s41408-021-00415-5 |
| _version_ | 1783649309293543424 |
|---|---|
| author | Brink, Mirian Visser, Otto Zweegman, Sonja Sonneveld, Pieter Broyl, Annemiek van de Donk, Niels W.C.J. Dinmohamed, Avinash G. |
| author_facet | Brink, Mirian Visser, Otto Zweegman, Sonja Sonneveld, Pieter Broyl, Annemiek van de Donk, Niels W.C.J. Dinmohamed, Avinash G. |
| author_sort | Brink, Mirian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7873037 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78730372021-02-16 First-line treatment and survival of newly diagnosed primary plasma cell leukemia patients in the Netherlands: a population-based study, 1989-2018 Brink, Mirian Visser, Otto Zweegman, Sonja Sonneveld, Pieter Broyl, Annemiek van de Donk, Niels W.C.J. Dinmohamed, Avinash G. Blood Cancer J Correspondence Nature Publishing Group UK 2021-02-04 /pmc/articles/PMC7873037/ /pubmed/33563890 http://dx.doi.org/10.1038/s41408-021-00415-5 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Brink, Mirian Visser, Otto Zweegman, Sonja Sonneveld, Pieter Broyl, Annemiek van de Donk, Niels W.C.J. Dinmohamed, Avinash G. First-line treatment and survival of newly diagnosed primary plasma cell leukemia patients in the Netherlands: a population-based study, 1989-2018 |
| title | First-line treatment and survival of newly diagnosed primary plasma cell leukemia patients in the Netherlands: a population-based study, 1989-2018 |
| title_full | First-line treatment and survival of newly diagnosed primary plasma cell leukemia patients in the Netherlands: a population-based study, 1989-2018 |
| title_fullStr | First-line treatment and survival of newly diagnosed primary plasma cell leukemia patients in the Netherlands: a population-based study, 1989-2018 |
| title_full_unstemmed | First-line treatment and survival of newly diagnosed primary plasma cell leukemia patients in the Netherlands: a population-based study, 1989-2018 |
| title_short | First-line treatment and survival of newly diagnosed primary plasma cell leukemia patients in the Netherlands: a population-based study, 1989-2018 |
| title_sort | first-line treatment and survival of newly diagnosed primary plasma cell leukemia patients in the netherlands: a population-based study, 1989-2018 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873037/ https://www.ncbi.nlm.nih.gov/pubmed/33563890 http://dx.doi.org/10.1038/s41408-021-00415-5 |
| work_keys_str_mv | AT brinkmirian firstlinetreatmentandsurvivalofnewlydiagnosedprimaryplasmacellleukemiapatientsinthenetherlandsapopulationbasedstudy19892018 AT visserotto firstlinetreatmentandsurvivalofnewlydiagnosedprimaryplasmacellleukemiapatientsinthenetherlandsapopulationbasedstudy19892018 AT zweegmansonja firstlinetreatmentandsurvivalofnewlydiagnosedprimaryplasmacellleukemiapatientsinthenetherlandsapopulationbasedstudy19892018 AT sonneveldpieter firstlinetreatmentandsurvivalofnewlydiagnosedprimaryplasmacellleukemiapatientsinthenetherlandsapopulationbasedstudy19892018 AT broylannemiek firstlinetreatmentandsurvivalofnewlydiagnosedprimaryplasmacellleukemiapatientsinthenetherlandsapopulationbasedstudy19892018 AT vandedonknielswcj firstlinetreatmentandsurvivalofnewlydiagnosedprimaryplasmacellleukemiapatientsinthenetherlandsapopulationbasedstudy19892018 AT dinmohamedavinashg firstlinetreatmentandsurvivalofnewlydiagnosedprimaryplasmacellleukemiapatientsinthenetherlandsapopulationbasedstudy19892018 |